Immunization and Infectious Diseases

Expand All Objectives Collapse All Objectives

Explore the latest data from the Immunization and Infectious Diseases and Global Health Progress Review [XLSX- 142 KB ]

IID-1 Reduce, eliminate, or maintain elimination of cases of vaccine-preventable diseases

IID-1.1 Maintain elimination of cases of vaccine-preventable congenital rubella syndrome (CRS) among children under 1 year of age (U.S.-acquired cases)

Baseline:

0 cases of confirmed and probable U.S.-acquired cases of congenital rubella syndrome were reported among children under 1 year of age in 2008

Target:

0 cases

Target-Setting Method:

Total elimination

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-01a. Browse data for HP2010 objective 14-01a

IID-1.2 Reduce serotype b cases of Haemophilus influenzae (Hib) invasive disease among children under age 5 years

Revised

This objective was revised. See Revision History for Details.

Baseline:

0.30 confirmed and probable cases of Haemophilus influenzae invasive disease per 100,000 children under age 5 years were reported in 2008

Target:

0.27 cases per 100,000 children under age 5 years

Target-Setting Method:

10 percent improvement

Data Sources:

Active Bacterial Core Surveillance (ABCS), CDC/NCIRD; Population Estimates, Census

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-01c. Browse data for HP2010 objective 14-01c

Revision History:

This objective was revised. Read more about the revision history.

IID-1.3 Reduce new hepatitis B cases among persons aged 2 to 18 years

Revised

This objective was revised. See Revision History for Details.

Baseline:

0.1 cases of new symptomatic hepatitis B per 100,000 persons aged 2 to 18 years were reported in 2007

Target:

0.0 cases per 100,000 persons aged 2 to 18 years

Target-Setting Method:

Total elimination

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS; Bridged-race Population Estimates, CDC/NCHS and Census

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-01d. Browse data for HP2010 objective 14-01d

Revision History:

This objective was revised. Read more about the revision history.

IID-1.4 Reduce measles cases (U.S.-acquired cases)

Baseline:

115 confirmed U.S.-acquired measles cases were reported in 2008

Target:

30 cases

Target-Setting Method:

Projection/trend analysis

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-01e. Browse data for HP2010 objective 14-01e

IID-1.5 Reduce cases of mumps (U.S.-acquired cases)

Baseline:

421 confirmed and probable U.S.-acquired cases of mumps were reported in 2008

Target:

500 cases

Target-Setting Method:

Projection/trend analysis

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-01f. Browse data for HP2010 objective 14-01f

IID-1.6 Reduce cases of pertussis among children under 1 year of age

Baseline:

2,777 confirmed and probable cases of pertussis (including cases identified in outbreak settings) among children under age 1 year was reported during 2004–08

Target:

2,500 cases among children under age 1 year

Target-Setting Method:

10 percent improvement

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-01g. Browse data for HP2010 objective 14-01g

IID-1.7 Reduce cases of pertussis among adolescents aged 11 to 18 years

Baseline:

3,995 confirmed and probable cases of pertussis (including cases identified in outbreak settings) were reported among adolescents aged 11 to 18 years during 2000–04

Target:

2,000 cases among adolescents aged 11 to 18 years

Target-Setting Method:

Projection/trend analysis

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

IID-1.8 Maintain elimination of acute paralytic poliomyelitis (U.S.-acquired cases)

Baseline:

0 cases of U.S.-acquired acute paralytic poliomyelitis were reported in 2008

Target:

0 cases

Target-Setting Method:

Total elimination

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-01h. Browse data for HP2010 objective 14-01h

IID-1.9 Maintain elimination of rubella (U.S.-acquired cases)

Baseline:

10 confirmed U.S.-acquired cases of rubella were reported in 2008

Target:

10 cases

Target-Setting Method:

Projection/trend analysis

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-01i. Browse data for HP2010 objective 14-01i

IID-1.10 Reduce cases of varicella (chicken pox) among persons aged 17 years of age or under

Baseline:

586,000 persons aged 17 years of age and under were reported to have had chicken pox (varicella) in the past year in 2008

Target:

100,000 persons aged 17 years of age and under

Target-Setting Method:

Projection/trend analysis

Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-01k. Browse data for HP2010 objective 14-01k

IID-2 Reduce early onset group B streptococcal disease

Revised

This objective was revised. See Revision History for Details.

Baseline:

0.30 newly reported cases of laboratory-confirmed early onset group B streptococcal disease were diagnosed among newborns aged 0 to 6 days per 1,000 live births in 2008

Target:

0.25 new cases among newborns aged 0 through 6 days per 1,000 live births

Target-Setting Method:

10 percent improvement

Data Sources:

Active Bacterial Core Surveillance (ABCS), CDC/NCIRD; National Vital Statistics System-Natality (NVSS-N), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-16. Browse data for HP2010 objective 14-16

Revision History:

This objective was revised. Read more about the revision history.

IID-3 Reduce meningococcal disease

Revised

This objective was revised. See Revision History for Details.

Baseline:

1,215 was the annual average of cases of new laboratory-confirmed meningococcal disease reported in 2004–08

Target:

1,094 cases

Target-Setting Method:

10 percent improvement

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-07. Browse data for HP2010 objective 14-07

Revision History:

This objective was revised. Read more about the revision history.

IID-4 Reduce invasive pneumococcal infections

IID-4.1 Reduce new invasive pneumococcal infections among children under age 5 years

Revised

This objective was revised. See Revision History for Details.

Baseline:

21.1 cases of laboratory-confirmed invasive pneumococcal infection were reported per 100,000 children under age 5 years in 2008

Target:

12.0 cases per 100,000 children under age 5 years

Target-Setting Method:

Projection/trend analysis

Data Sources:

Active Bacterial Core Surveillance (ABCS), CDC/NCIRD; Bridged-race Population Estimates, CDC/NCHS and Census

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by sex Disparities by race and ethnicity
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-05a. Browse data for HP2010 objective 14-05a

Revision History:

This objective was revised. Read more about the revision history.

IID-4.2 Reduce new invasive pneumococcal infections among adults aged 65 years and older

Revised

This objective was revised. See Revision History for Details.

Baseline:

40.7 new cases of laboratory-confirmed invasive pneumococcal infection per 100,000 adults aged 65 years and over were diagnosed in 2008

Target:

31.0 new cases per 100,000 adults aged 65 years and older

Target-Setting Method:

Projection/trend analysis

Data Sources:

Active Bacterial Core Surveillance (ABCS), CDC/NCIRD; Bridged-race Population Estimates, CDC/NCHS and Census

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-05b. Browse data for HP2010 objective 14-05b

Revision History:

This objective was revised. Read more about the revision history.

IID-4.3 Reduce invasive antibiotic-resistant pneumococcal infections among children under age 5 years

Revised

This objective was revised. See Revision History for Details.

Baseline:

8.3 new cases of laboratory-confirmed invasive antibiotic-resistant pneumococcal infection per 100,000 children under age 5 years were diagnosed in 2008

Target:

6.0 new cases per 100,000 children under age 5 years

Target-Setting Method:

Projection/trend analysis

Data Sources:

Active Bacterial Core Surveillance (ABCS), CDC/NCIRD; Bridged-race Population Estimates, CDC/NCHS and Census

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by race and ethnicity
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-05c. Browse data for HP2010 objective 14-05c

Revision History:

This objective was revised. Read more about the revision history.

IID-4.4 Reduce invasive antibiotic-resistant pneumococcal infections among adults aged 65 years and older

Revised

This objective was revised. See Revision History for Details.

Baseline:

12.2 new cases of laboratory-confirmed invasive antibiotic-resistant pneumococcal infection per 100,000 adults aged 65 years and over were diagnosed in 2008

Target:

9.0 new cases per 100,000 population adults aged 65 years and older

Target-Setting Method:

Projection/trend analysis

Data Sources:

Active Bacterial Core Surveillance (ABCS), CDC/NCIRD; Bridged-race Population Estimates, CDC/NCHS and Census

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by sex
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-05d. Browse data for HP2010 objective 14-05d

Revision History:

This objective was revised. Read more about the revision history.

IID-5 Reduce outpatient visits for ear infections where antibiotics were prescribed to young children

Revised

This objective was revised. See Revision History for Details.

Baseline:

77.8 percent of outpatient visits for ear infections in children under 5 years had an antibiotic prescribed to them for ear infection in 2006–07

Target:

70.0 percent of outpatient visits

Target-Setting Method:

10 percent improvement

Data Sources:

National Ambulatory Medical Care Survey (NAMCS), CDC/NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by sex Disparities by race and ethnicity
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-18. Browse data for HP2010 objective 14-18

Revision History:

This objective was revised. Read more about the revision history.

IID-6 Reduce outpatient visits where antibiotics were prescribed for the sole diagnosis of the common cold

Revised

This objective was revised. See Revision History for Details.

Baseline:

28.6 percent of outpatient visits for those whose sole diagnosis was the common cold were prescribed antibiotics in 2006–07

Target:

21.0 percent of outpatient visits

Target-Setting Method:

Minimal statistical significance

Data Sources:

National Ambulatory Medical Care Survey (NAMCS), CDC/NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by sex Disparities by race and ethnicity Disparities by age group
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-19. Browse data for HP2010 objective 14-19

Revision History:

This objective was revised. Read more about the revision history.

IID-7 Achieve and maintain effective vaccination coverage levels for universally recommended vaccines among young children

IID-7.1 Maintain an effective vaccination coverage level of 4 doses of the diphtheria-tetanus-acellular pertussis (DTaP) vaccine among children by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

82.5 percent of children aged 19 to 35 months in 2012 received 4 or more doses of the combination of diphtheria, tetanus, and acellular pertussis antigens

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by sex Disparities by race and ethnicity Disparities by family income (percent poverty threshold)
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-22a. Browse data for HP2010 objective 14-22a

Revision History:

This objective was revised. Read more about the revision history.

IID-7.2 Achieve and maintain an effective vaccination coverage level of 3 or 4 doses of Haemophilus influenzae type b (Hib) vaccine among children by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

80.9 percent of children aged 19 to 35 months in 2012 received 3 or more, or 4 or more doses of Hib antigen, depending on product type received

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by sex Disparities by race and ethnicity Disparities by family income (percent poverty threshold)
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-22b. Browse data for HP2010 objective 14-22b

Revision History:

This objective was revised. Read more about the revision history.

IID-7.3 Maintain an effective vaccination coverage level of 3 doses of hepatitis B (hep B) vaccine among children by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

89.7 percent of children aged 19 to 35 months in 2012 received at least 3 doses of the hepatitis B antigen

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by health insurance status Disparities by sex Disparities by race and ethnicity Disparities by educational attainment Disparities by family income (percent poverty threshold) Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-22c. Browse data for HP2010 objective 14-22c

Revision History:

This objective was revised. Read more about the revision history.

IID-7.4 Maintain an effective coverage level of 1 dose of measles-mumps-rubella (MMR) vaccine among children by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

90.8 percent of children aged 19 to 35 months in 2012 received at least 1 dose of measles-mumps-rubella (MMR) vaccine

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by health insurance status Disparities by sex Disparities by race and ethnicity Disparities by educational attainment Disparities by family income (percent poverty threshold) Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-22d. Browse data for HP2010 objective 14-22d

Revision History:

This objective was revised. Read more about the revision history.

IID-7.5 Maintain an effective coverage level of 3 doses of polio vaccine among children by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

92.8 percent of children aged 19 to 35 months in 2012 received at least 3 doses of polio vaccine

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by health insurance status Disparities by sex Disparities by race and ethnicity Disparities by educational attainment Disparities by family income (percent poverty threshold) Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-22e. Browse data for HP2010 objective 14-22e

Revision History:

This objective was revised. Read more about the revision history.

IID-7.6 Maintain an effective coverage level of 1 dose of varicella vaccine among children by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

90.2 percent of children aged 19 to 35 months in 2012 received at least 1 dose of the varicella antigen

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by sex Disparities by race and ethnicity Disparities by educational attainment Disparities by family income (percent poverty threshold) Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-22f. Browse data for HP2010 objective 14-22f

Revision History:

This objective was revised. Read more about the revision history.

IID-7.7 Achieve and maintain an effective coverage level of 4 doses of pneumococcal conjugate vaccine (PCV) among children by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

81.9 percent of children aged 19 to 35 months received at least 4 doses of pneumococcal conjugate vaccine in 2012

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by sex Disparities by race and ethnicity
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-22g. Browse data for HP2010 objective 14-22g

Revision History:

This objective was revised. Read more about the revision history.

IID-7.8 Achieve and maintain an effective coverage level of 2 doses of hepatitis A vaccine among children by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

53.0 percent of children aged 19 to 35 months in 2012 received 2 or more doses of hepatitis A vaccine

Target:

85.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by sex Disparities by race and ethnicity Disparities by educational attainment
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-7.9 Achieve and maintain an effective coverage level of a birth dose of hepatitis B vaccine (0 to 3 days between birth date and date of vaccination, reported by annual birth cohort)

Revised

This objective was revised. See Revision History for Details.

Baseline:

70.6 percent of the 2005 birth cohort received the first dose of hepatitis B vaccine within 3 days of birth based on National Immunization Survey data from 2010–12

Target:

85.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by health insurance status Disparities by sex Disparities by educational attainment Disparities by family income (percent poverty threshold)
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-7.10 Achieve and maintain an effective coverage level of 2 or more or 3 or more doses rotavirus vaccine among children by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

68.6 percent of children aged 19 to 35 months in 2012 received 2 or more, or 3 or more doses of rotavirus vaccine by age 19 to 35 months, depending on product type received

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by sex Disparities by race and ethnicity
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-8 Increase the percentage of children aged 19 to 35 months who receive the recommended doses of DTaP, polio, MMR, Hib, hepatitis B, varicella and pneumococcal conjugate vaccine (PCV)

LHI

Leading Health Indicators are a subset of Healthy People 2020 objectives selected to communicate high-priority health issues.

Revised

This objective was revised. See Revision History for Details.

Baseline:

68.4 percent of children aged 19 to 35 months in 2012 received the recommended doses of DTaP, polio, MMR, Hib, hepatitis B, varicella, and PCV

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by sex
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-24a. Browse data for HP2010 objective 14-24a

Revision History:

This objective was revised. Read more about the revision history.

More Information:

Related research articles on PubMed

IID-9 Decrease the percentage of children in the United States who receive 0 doses of recommended vaccines by age 19 to 35 months

Revised

This objective was revised. See Revision History for Details.

Baseline:

0.8 percent of children aged 19 to 35 months in 2012 in the United States received 0 doses of recommended vaccines by age 19 to 35 months

Target:

Not applicable

Target-Setting Method:

This measure is being tracked for informational purposes. If warranted, a target will be set during the decade.

Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by health insurance status Disparities by sex Disparities by educational attainment Disparities by family income (percent poverty threshold)
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-10 Maintain vaccination coverage levels for children in kindergarten

IID-10.1 Maintain the vaccination coverage level of 4 doses of diphtheria-tetanus-acellular pertussis (DTaP) vaccine for children in kindergarten

Revised

This objective was revised. See Revision History for Details.

Baseline:

97.2 percent of children enrolled in kindergarten for the 2009–10 school year received 4 or more doses of DTaP vaccine

Target:

95.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Annual School Assessment Reports, CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-23f. Browse data for HP2010 objective 14-23f

Revision History:

This objective was revised. Read more about the revision history.

IID-10.2 Maintain the vaccination coverage level of 2 doses of measles-mumps-rubella (MMR) vaccine for children in kindergarten

Revised

This objective was revised. See Revision History for Details.

Baseline:

95.0 percent of children enrolled in kindergarten for the 2009–10 school year received 2 or more doses of MMR vaccine

Target:

95.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Annual School Assessment Reports, CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-23g. Browse data for HP2010 objective 14-23g

Revision History:

This objective was revised. Read more about the revision history.

IID-10.3 Maintain the vaccination coverage level of 3 doses of polio vaccine for children in kindergarten

Revised

This objective was revised. See Revision History for Details.

Baseline:

96.2 percent of children enrolled in kindergarten for the 2009–10 school year received 3 or more doses of polio vaccine

Target:

95.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Annual School Assessment Reports, CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-23h. Browse data for HP2010 objective 14-23h

Revision History:

This objective was revised. Read more about the revision history.

IID-10.4 Maintain the vaccination coverage level of 3 doses of hepatitis B vaccine for children in kindergarten

Revised

This objective was revised. See Revision History for Details.

Baseline:

97.0 percent of children enrolled in kindergarten for the 2009–10 school year received 3 or more doses of hepatitis B vaccine

Target:

95.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Annual School Assessment Reports, CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-23i. Browse data for HP2010 objective 14-23i

Revision History:

This objective was revised. Read more about the revision history.

IID-10.5 Maintain the vaccination coverage level of 2 doses of varicella vaccine for children in kindergarten

Revised

This objective was revised. See Revision History for Details.

Baseline:

91.3 percent of children enrollees in kindergarten received 2 or more doses of varicella vaccine in the 2009–10 school year

Target:

95.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Annual School Assessment Reports, CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-23j. Browse data for HP2010 objective 14-23j

Revision History:

This objective was revised. Read more about the revision history.

IID-11 Increase routine vaccination coverage levels for adolescents

IID-11.1 Increase the vaccination coverage level of 1 dose of tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine for adolescents by age 13 to 15 years

Revised

This objective was revised. See Revision History for Details.

Baseline:

85.3 percent of adolescents aged 13 to 15 years had received at least 1 dose of a Tdap booster in 2012

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey-Teen (NIS-Teen), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by sex Disparities by race and ethnicity Disparities by educational attainment Disparities by family income (percent poverty threshold) Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-27c. Browse data for HP2010 objective 14-27c

Revision History:

This objective was revised. Read more about the revision history.

IID-11.2 Increase the vaccination coverage level of 2 doses of varicella vaccine for adolescents by age 13 to 15 years (excluding children who have had varicella)

Revised

This objective was revised. See Revision History for Details.

Baseline:

76.8 percent of adolescents aged 13 to 15 years had received at least 2 doses of varicella vaccine (excluding adolescents who have had varicella) in 2012

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey-Teen (NIS-Teen), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by geographic location Disparities by sex Disparities by race and ethnicity Disparities by educational attainment Disparities by family income (percent poverty threshold) Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-27d. Browse data for HP2010 objective 14-27d

Revision History:

This objective was revised. Read more about the revision history.

IID-11.3 Increase the vaccination coverage level of 1 dose meningococcal conjugate vaccine for adolescents by age 13 to 15 years

Revised

This objective was revised. See Revision History for Details.

Baseline:

73.8 percent of adolescents aged 13 to 15 years had received at least 1 dose of meningococcal conjugate vaccine in 2012

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey-Teen (NIS-Teen), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by sex Disparities by race and ethnicity Disparities by educational attainment Disparities by family income (percent poverty threshold) Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-11.4 Increase the percentage of female adolescents aged 13 through 15 years who receive 2 or 3 doses of human papillomavirus (HPV) vaccine as recommended

Revised

This objective was revised. See Revision History for Details.

Baseline:

45.1 percent of female adolescents aged 13 through 15 years had received the ACIP-recommended number of appropriately spaced doses of human papillomavirus (HPV) vaccine by 2016 based on their age at initiation of HPV vaccination

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey-Teen (NIS-Teen), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by race and ethnicity Disparities by family income (percent poverty threshold) Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-11.5 Increase the percentage of male adolescents aged 13 through 15 years who receive 2 or 3 doses of human papillomavirus (HPV) vaccine as recommended

Revised

This objective was revised. See Revision History for Details.

Baseline:

36.4 percent of male adolescents aged 13 through 15 years had received the ACIP-recommended number of appropriately spaced doses of human papillomavirus (HPV) vaccine by 2016 based on their age at initiation of HPV vaccination

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Immunization Survey-Teen (NIS-Teen), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by race and ethnicity Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-12 Increase the percentage of children and adults who are vaccinated annually against seasonal influenza

IID-12.1 Increase the percentage of children aged 6 to 23 months who are vaccinated annually against seasonal influenza (1 or 2 doses, depending on age-appropriateness and previous doses received)

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline:

23.4 percent of children aged 6 to 23 months received 1 or 2 doses of influenza vaccine in 2008

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Potential Data Sources:

National Immunization Survey (NIS), CDC/NCIRD and CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-22h. Browse data for HP2010 objective 14-22h

Revision History:

This objective was archived due to a change in policy. Read more about the revision history.

IID-12.2 Increase the percentage of children aged 2 to 4 years who are vaccinated annually against seasonal influenza

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline:

39.6 percent of children aged 2 to 4 years received influenza vaccine in 2008

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Potential Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was archived due to a change in policy. Read more about the revision history.

IID-12.3 Increase the percentage of children aged 5 to 12 years who are vaccinated annually against seasonal influenza

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline:

25.8 percent of children aged 5 to 12 years received influenza vaccine in 2008

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Potential Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was archived due to a change in policy. Read more about the revision history.

IID-12.4 Increase the percentage of children aged 13 to 17 years who are vaccinated annually against seasonal influenza

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline:

9.8 percent of children aged 13 to 17 years received influenza vaccine in 2008

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Potential Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was archived due to a change in policy. Read more about the revision history.

IID-12.5 Increase the percentage of noninstitutionalized adults aged 18 to 64 years who are vaccinated annually against seasonal influenza

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline:

24.9 percent of noninstitutionalized adults aged 18 to 64 years received influenza vaccine in 2008

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Potential Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was archived due to a change in policy. Read more about the revision history.

IID-12.6 Increase the percentage of noninstitutionalized high-risk adults aged 18 to 64 years who are vaccinated annually against seasonal influenza

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline:

38.6 percent of noninstitutionalized high-risk adults aged 18 to 64 years received influenza vaccine in 2008

Target:

90.0 percent

Target-Setting Method:

Retention of Healthy People 2010 target

Potential Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-29c. Browse data for HP2010 objective 14-29c

Revision History:

This objective was archived due to a change in policy. Read more about the revision history.

IID-12.7 Increase the percentage of noninstitutionalized adults aged 65 years and older who are vaccinated annually against seasonal influenza

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline:

66.6 percent of noninstitutionalized adults aged 65 years and older received influenza vaccine in 2008

Target:

90.0 percent

Target-Setting Method:

Retention of Healthy People 2010 target

Potential Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-29a. Browse data for HP2010 objective 14-29a

Revision History:

This objective was archived due to a change in policy. Read more about the revision history.

IID-12.8 Increase the percentage of institutionalized adults aged 18 years and older in long-term or nursing homes who are vaccinated annually against seasonal influenza

Revised

This objective was revised. See Revision History for Details.

Baseline:

71.4 percent of institutionalized adults 18 years and older in long-term or nursing homes received influenza vaccine for the 2005–06 influenza season

Target:

90.0 percent

Target-Setting Method:

Retention of Healthy People 2010 target

Data Sources:

Minimum Data Set (MDS), CMS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by marital status Disparities by sex Disparities by race and ethnicity
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-29e. Browse data for HP2010 objective 14-29e

Revision History:

This objective was revised. Read more about the revision history.

IID-12.9 Increase the percentage of health care personnel who are vaccinated annually against seasonal influenza

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline:

45.5 percent of health care personnel received influenza vaccine in 2008

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Potential Data Sources:

Minimum Data Set (MDS), CMS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-29g. Browse data for HP2010 objective 14-29g

Revision History:

This objective was archived due to a change in policy. Read more about the revision history.

IID-12.10 Increase the percentage of pregnant women who are vaccinated against seasonal influenza

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Baseline:

27.6 percent of pregnant women received influenza vaccine in 2008

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Potential Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was archived due to a change in policy. Read more about the revision history.

IID-12.11 Increase the percentage of children aged 6 months through 17 years who are vaccinated annually against seasonal influenza

Revised

This objective was revised. See Revision History for Details.

Baseline:

46.9 percent of children aged 6 months through 17 years were vaccinated against influenza during the 2010–11 influenza season

Target:

70.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by sex Disparities by country of birth
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-22h. Browse data for HP2010 objective 14-22h

Revision History:

This objective was revised. Read more about the revision history.

IID-12.12 Increase the percentage of noninstitutionalized adults aged 18 and older who are vaccinated annually against seasonal influenza

Revised

This objective was revised. See Revision History for Details.

Baseline:

38.1 percent of noninstitutionalized adults aged 18 years and older were vaccinated against influenza during the 2010–11 influenza season

Target:

70.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by country of birth
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objectives with the same definition were 14-29a, 14-19c, 14-29e. Browse data for HP2010 objective 14-29a, 14-19c, 14-29e

Revision History:

This objective was revised. Read more about the revision history.

IID-12.13 Increase the percentage of health care personnel who are vaccinated annually against seasonal influenza

Revised

This objective was revised. See Revision History for Details.

Baseline:

55.8 percent of health care personnel were vaccinated against influenza during the 2010–11 influenza season

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by marital status Disparities by obesity status Disparities by sex Disparities by race and ethnicity Disparities by age group Disparities by family income (percent poverty threshold) Disparities by family type Disparities by country of birth
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-29g. Browse data for HP2010 objective 14-29g

Revision History:

This objective was revised. Read more about the revision history.

IID-12.14 Increase the percentage of pregnant women who are vaccinated against seasonal influenza

Revised

This objective was revised. See Revision History for Details.

Baseline:

40.4 percent of pregnant women were vaccinated against seasonal influenza during the 2012–13 influenza season

Target:

80.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by health insurance status Disparities by race and ethnicity Disparities by educational attainment Disparities by family income (percent poverty threshold) Disparities by country of birth
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-13 Increase the percentage of adults who are vaccinated against pneumococcal disease

IID-13.1 Increase the percentage of noninstitutionalized adults aged 65 years and older who are vaccinated against pneumococcal disease

Baseline:

60.0 percent of persons aged 65 years and over in 2008 had ever received a pneumococcal vaccination

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by obesity status Disparities by sex Disparities by age group
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-29b. Browse data for HP2010 objective 14-29b

IID-13.2 Increase the percentage of noninstitutionalized high-risk adults aged 18 to 64 years who are vaccinated against pneumococcal disease

Baseline:

16.6 percent of high-risk persons aged 18 to 64 years in 2008 had ever received a pneumococcal vaccination

Target:

60.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by race and ethnicity Disparities by age group Disparities by educational attainment
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-29d. Browse data for HP2010 objective 14-29d

IID-13.3 Increase the percentage of institutionalized adults (persons aged 18 years and older in long-term or nursing homes) who are vaccinated against pneumococcal disease

Revised

This objective was revised. See Revision History for Details.

Baseline:

70.8 percent of persons in long-term care facilities and nursing homes certified by the Centers for Medicare and Medicaid Services (CMS) reported having up-to-date pneumococcal vaccinations in 2015

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Minimum Data Set (MDS), CMS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by sex Disparities by race and ethnicity
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-29f. Browse data for HP2010 objective 14-29f

Revision History:

This objective was revised. Read more about the revision history.

IID-14 Increase the percentage of adults who are vaccinated against zoster (shingles)

Baseline:

6.7 percent of adults aged 60 years and over in 2008 had received zoster (shingles) vaccine

Target:

30.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by obesity status
	Details about the methodology and measurement of this HP2020 objective

IID-15 (Developmental) Increase hepatitis B vaccine coverage among high-risk populations

IID-15.1 (Developmental) Increase hepatitis B vaccine coverage among long-term hemodialysis patients

Potential Data Sources:

To be determined

Data:

The HP2010 objective with the same definition was 14-28a.
Browse data for HP2010 objective 14-28a

IID-15.2 (Developmental) Increase hepatitis B vaccine coverage among men who have sex with men

Potential Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

The HP2010 objective with the same definition was 14-28b.
Browse data for HP2010 objective 14-28b

IID-15.3 Increase hepatitis B vaccine coverage among health care personnel

Baseline:

64.3 percent of health care personnel in 2008 had received at least 3 doses of hepatitis B vaccine

Target:

90.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Health Interview Survey (NHIS), CDC/NCHS

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by obesity status Disparities by sex Disparities by country of birth
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-28c. Browse data for HP2010 objective 14-28c

IID-15.4 (Developmental) Increase hepatitis B vaccine coverage among injection drug users

Potential Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

IID-16 (Developmental) Increase the scientific knowledge on vaccine safety and adverse events

Archived

This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.

Potential Data Sources:

Vaccine Adverse Event Reporting System (VAERS), CDC and FDA

Data:

The HP2010 objective with the same definition was 14-31a.
Browse data for HP2010 objective 14-31a

Revision History:

This objective was archived due to a change in science. Read more about the revision history.

IID-17 Increase the percentage of providers who have had vaccination coverage levels among children in their practice population measured within the past year

IID-17.1 Increase the percentage of public health providers who have had vaccination coverage levels among children in their practice population measured within the past year

Revised

This objective was revised. See Revision History for Details.

Baseline:

40.0 percent of public provider sites that routinely provided immunizations to children aged 6 years and under participated in a provider assessment at least once in the past year in 2009

Target:

50.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Program Annual Progress Assessments (PAPA), CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-25a. Browse data for HP2010 objective 14-25a

Revision History:

This objective was revised. Read more about the revision history.

IID-17.2 Increase the percentage of private providers who have had vaccination coverage levels among children in their practice population measured within the past year

Revised

This objective was revised. See Revision History for Details.

Baseline:

33.0 percent of private provider sites that routinely provided immunizations to children aged 6 years and under participated in a provider assessment at least once in the past year in 2009

Target:

50.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Program Annual Progress Assessments (PAPA), CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-25b. Browse data for HP2010 objective 14-25b

Revision History:

This objective was revised. Read more about the revision history.

IID-18 Increase the percentage of children under age 6 years of age whose immunization records are in a fully operational, population-based immunization information system (IIS)

Revised

This objective was revised. See Revision History for Details.

Baseline:

75.0 percent of children under 6 years of age had two or more immunizations recorded in the immunization information system (IIS) in 2008

Target:

95.0 percent

Target-Setting Method:

Projection/trend analysis

Data Sources:

Immunization Information Systems Annual Report (IISAR), CDC/NCIRD; Population Estimates, Census

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-26. Browse data for HP2010 objective 14-26

Revision History:

This objective was revised. Read more about the revision history.

IID-19 Increase the number of States collecting kindergarten vaccination coverage data according to CDC minimum standards

Revised

This objective was revised. See Revision History for Details.

Baseline:

11 States (including the District of Columbia) collected kindergarten vaccination coverage data according to CDC minimum standards in 2009–10

Target:

51 (States and the District of Columbia)

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Annual School Assessment Reports, CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-20 Increase the number of States, the District of Columbia, and other reporting areas that have 80 percent of adolescents with 2 or more age-appropriate immunizations recorded in an immunization information system (IIS) among adolescents aged 11 to 18 years

Revised

This objective was revised. See Revision History for Details.

Baseline:

11 States, the District of Columbia, and other reporting areas recorded 80 percent of adolescents aged 11 to 18 years with 2 or more age-appropriate immunizations in an immunization information system (IIS) in 2012

Target:

40 States, the District of Columbia, and other reporting areas

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Immunization Information Systems Annual Report (IISAR), CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-21 Increase the number of States that use electronic data from rabies animal surveillance to inform public health prevention programs

Baseline:

8 States used electronic data from rabies animal surveillance to inform public health prevention programs in 2010

Target:

52 States (excluding Hawaii), the District of Columbia, Puerto Rico, and New York City

Target-Setting Method:

Projection/trend analysis

Data Sources:

Rabies Surveillance Network (RSN), CDC/NCEZID

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

IID-22 Increase the number of public health laboratories monitoring influenza virus resistance to antiviral agents

Baseline:

3 public health laboratories monitored influenza virus resistance to antiviral agents in 2009

Target:

25 public health laboratories

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

State Public Health Laboratories Performing Antiviral Resistance Testing, CDC/NCIRD

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

IID-23 Reduce hepatitis A

Revised

This objective was revised. See Revision History for Details.

Baseline:

1.0 cases of hepatitis A virus per 100,000 population were reported in 2007

Target:

0.3 cases per 100,000 population

Target-Setting Method:

Projection/trend analysis

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS; Bridged-race Population Estimates, CDC/NCHS and Census

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by age group
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-06. Browse data for HP2010 objective 14-06

Revision History:

This objective was revised. Read more about the revision history.

IID-24 Reduce chronic hepatitis B virus infections in infants and young children (perinatal infections)

Baseline:

799 cases of chronic hepatitis B virus (HBV) infection are estimated among infants and children aged 1 to 24 months who were born to mothers with HBV infections in 2007

Target:

400 cases

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Vital Statistics System-Natality (NVSS-N), CDC/NCHS; Perinatal Hepatitis B Prevention Program (PHBPP), CDC/NCHHSTP

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-02. Browse data for HP2010 objective 14-02

IID-25 Reduce hepatitis B

IID-25.1 Reduce new hepatitis B infections in adults aged 19 and older

Revised

This objective was revised. See Revision History for Details.

Baseline:

2.0 symptomatic cases of hepatitis B per 100,000 persons aged 19 years and over were reported in 2007

Target:

1.5 cases per 100,000

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS; Bridged-race Population Estimates, CDC/NCHS and Census

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by race and ethnicity Disparities by age group
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objectives with the same definition were 14-03a through 14-03c. Browse data for HP2010 objectives: 14-03a, 14-03b, 14-03c

Revision History:

This objective was revised. Read more about the revision history.

IID-25.2 Reduce new hepatitis B infections among high-risk populations—Injection drug users

Baseline:

285 symptomatic cases of hepatitis B were reported among injection drug users in 2007

Target:

215 cases

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-03d. Browse data for HP2010 objective 14-03d

IID-25.3 Reduce new hepatitis B infections among high-risk populations—Men who have sex with men

Baseline:

62 new hepatitis B infections were reported among men who indicated homosexual or bisexual preference in 2007

Target:

45 new infections

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-03f. Browse data for HP2010 objective 14-03f

IID-26 Reduce new hepatitis C infections

Revised

This objective was revised. See Revision History for Details.

Baseline:

0.28 new symptomatic hepatitis C cases per 100,000 population were reported in the past 12 months in 2007

Target:

0.25 new cases per 100,000

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National Notifiable Diseases Surveillance System (NNDSS), CDC/CSELS; Bridged-race Population Estimates, CDC/NCHS and Census

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by race and ethnicity Disparities by age group
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-09. Browse data for HP2010 objective 14-09

Revision History:

This objective was revised. Read more about the revision history.

IID-27 Increase the proportion of persons aware they have a hepatitis C infection

Revised

This objective was revised. See Revision History for Details.

Baseline:

53.0 percent of National Health and Nutrition Examination Survey respondents who tested positive for chronic hepatitis C reported that they were aware of their hepatitis C infection status prior to the laboratory confirmation in 2003–08

Target:

60.0 percent

Target-Setting Method:

Projection/trend analysis

Data Sources:

National Health and Nutrition Examination Survey (NHANES), CDC/NCHS

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective

Revision History:

This objective was revised. Read more about the revision history.

IID-28 (Developmental) Increase the proportion of persons who have been tested for hepatitis B virus within minority communities experiencing health disparities

Potential Data Sources:

REACH (Racial and Ethnic Approaches to Community Health) Risk Factor Survey, CDC

IID-29 Reduce tuberculosis (TB)

Revised

This objective was revised. See Revision History for Details.

Baseline:

4.8 confirmed new cases of tuberculosis per 100,000 population were reported to CDC by local health departments in all 50 States and the District of Columbia in 2005

Target:

1.0 new case per 100,000 population

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National TB Surveillance System (NTSS), CDC/NCHHSTP; Bridged-race Population Estimates, CDC/NCHS and Census

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by race and ethnicity Disparities by age group Disparities by country of birth
	Map of state-level data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-11. Browse data for HP2010 objective 14-11

Revision History:

This objective was revised. Read more about the revision history.

IID-30 Increase treatment completion rate of all tuberculosis patients who are eligible to complete therapy

Revised

This objective was revised. See Revision History for Details.

Baseline:

81.9 percent of persons with confirmed tuberculosis completed curative therapy in 2005

Target:

93.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National TB Surveillance System (NTSS), CDC/NCHHSTP

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by in long-term care facility Disparities by sex Disparities by hiv infection Disparities by age group Disparities by country of birth
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-12. Browse data for HP2010 objective 14-12

Revision History:

This objective was revised. Read more about the revision history.

IID-31 Increase the percentage of contacts to sputum smear-positive tuberculosis cases who complete treatment after being diagnosed with latent tuberculosis infection (LTBI) and initiated treatment for LTBI

Revised

This objective was revised. See Revision History for Details.

Baseline:

68.1 percent of contacts to sputum smear-positive tuberculosis cases completed treatment after being diagnosed with latent tuberculosis infection (LTBI) and initiated treatment for LTBI in 2007

Target:

79.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

Aggregate Reports for Tuberculosis Program Evaluation, CDC/NCHHSTP; National TB Surveillance System (NTSS), CDC/NCHHSTP

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-13. Browse data for HP2010 objective 14-13

Revision History:

This objective was revised. Read more about the revision history.

IID-32 Increase the proportion of culture-confirmed TB patients with a positive nucleic acid amplification test (NAAT) result reported within 2 days of specimen collection

Revised

This objective was revised. See Revision History for Details.

Baseline:

32.0 percent of culture-confirmed TB patients with a positive nucleic acid amplification test (NAAT) had their test results reported within 2 days of specimen collection in 2008

Target:

77.0 percent

Target-Setting Method:

Maintain consistency with national programs, regulations, policies, and laws.

Data Sources:

National TB Surveillance System (NTSS), CDC/NCHHSTP

Data:

	HP2020 data for this objective
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 14-14. Browse data for HP2010 objective 14-14

Revision History:

This objective was revised. Read more about the revision history.

IID-33 Increase the proportion of adults with tuberculosis (TB) who have been tested for HIV

Moved

This objective was moved from a different topic area. See Revision History for Details.

Baseline:

73.3 percent of persons aged 25 to 44 years with TB were tested for HIV in 2008

Target:

80.6 percent

Target-Setting Method:

10 percent improvement

Data Sources:

National TB Surveillance System (NTSS), CDC/NCHHSTP

Data:

	HP2020 data for this objective
	Spotlight on Disparities: Disparities by sex Disparities by race and ethnicity
	Details about the methodology and measurement of this HP2020 objective
	The HP2010 objective with the same definition was 13-11. Browse data for HP2010 objective 13-11